Calibra Medical, Inc. was a Redwood City, California medical device company founded in 2004 to make mealtime insulin therapy simpler and more discreet. Its product was the Finesse "patch-pen", a fully mechanical, three-day wearable bolus insulin delivery patch (roughly 2 x 1 x 0.25 inches, 200-unit reservoir, no batteries, display, or handheld controller) dosed by pressing two buttons. Backed by Canaan Partners, Frazier Healthcare Partners, Intersouth Partners, Skyline Ventures, and Three Arch Partners, the company raised approximately $61.5M before Johnson & Johnson acquired it in a reported $77M all-cash deal in 2012, folding it into the J&J Diabetes Care Companies. J&J rebranded the device OneTouch Via but never commercially launched it, and on July 17, 2018 sold select Calibra Medical assets and an exclusive worldwide license to Swiss wearable-insulin firm CeQur. Calibra Medical no longer operates as an independent company: it publishes no developer portal, no API, and no public source repositories, and the calibramedical.com domain now resolves to a parked "domain may be for sale" page. This profile is retained as a historical medical-device company record with no API surface.
Calibra Medical is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Diabetes, Insulin Delivery, and Health.
aid: calibra-medical
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source: []
generated: '2026-07-22'
method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/calibra-medical.png
name: Calibra Medical
description: 'Calibra Medical, Inc. was a Redwood City, California medical device company founded in 2004 to make mealtime
insulin therapy simpler and more discreet. Its product was the Finesse "patch-pen", a fully mechanical, three-day wearable
bolus insulin delivery patch (roughly 2 x 1 x 0.25 inches, 200-unit reservoir, no batteries, display, or handheld controller)
dosed by pressing two buttons. Backed by Canaan Partners, Frazier Healthcare Partners, Intersouth Partners, Skyline Ventures,
and Three Arch Partners, the company raised approximately $61.5M before Johnson & Johnson acquired it in a reported $77M
all-cash deal in 2012, folding it into the J&J Diabetes Care Companies. J&J rebranded the device OneTouch Via but never
commercially launched it, and on July 17, 2018 sold select Calibra Medical assets and an exclusive worldwide license to
Swiss wearable-insulin firm CeQur. Calibra Medical no longer operates as an independent company: it publishes no developer
portal, no API, and no public source repositories, and the calibramedical.com domain now resolves to a parked "domain may
be for sale" page. This profile is retained as a historical medical-device company record with no API surface.'
url: https://raw.githubusercontent.com/api-evangelist/calibra-medical/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: defunct-no-api-surface
x-status: acquired
x-founded: '2004'
x-headquarters: Redwood City, California, United States
x-acquisition:
- acquirer: Johnson & Johnson
year: '2012'
detail: Reported $77M all-cash acquisition; operated as one of the J&J Diabetes Care Companies. Device rebranded OneTouch
Via but never commercially launched.
- acquirer: CeQur SA
date: '2018-07-17'
detail: Acquired select assets of Calibra Medical, Inc. plus an exclusive worldwide license to the wearable on-demand insulin
delivery system formerly known as OneTouch Via.
source: https://www.prnewswire.com/news-releases/cequr-acquires-assets-from-calibra-medical-inc-300681711.html
x-investors:
- Canaan Partners
- Frazier Healthcare Partners
- Intersouth Partners
- Skyline Ventures
- Three Arch Partners
x-former-domain: calibramedical.com
x-domain-status: parked-for-sale
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Medical Devices
- Diabetes
- Insulin Delivery
- Health
- Wearables
- Drug Delivery
- Acquired
apis: []
common: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
x-enrichment:
date: '2026-07-20'
status: minimal
artifacts_added: 0
pass: local-v1
notes: Searched company history, the Canaan Partners portfolio page, and the acquisition record; probed calibramedical.com
(HTTP 200, parked "domain may be for sale" page), /.well-known/security.txt, /.well-known/openid-configuration, /.well-known/api-catalog,
and /llms.txt (all HTTP 404), plus GitHub orgs calibra-medical and calibramedical (both HTTP 404). No API, developer portal,
SDK, or public repository surface exists. Company defunct as an independent entity since the 2012 Johnson & Johnson acquisition;
assets sold to CeQur 2018-07-17.
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.